A novel predictor for the use of concurrent chemotherapy in early-stage cervical cancer with intermediate-risk factors
Objective: For early-stage cervical cancer patients experiencing radical surgery, postoperative radiotherapy was recommended for patients with a combination of intermediate-risk factors. However, there was no consensus on whether to administer concurrent chemotherapy. The aim of the study was to con...
Saved in:
Main Authors: | Chunli Fu (Author), Cong Wang (Author), Qiuhong Qian (Author), Youzhong Zhang (Author), Changdong Ma (Author), Li Miao (Author), Guangyu Zhang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Benign metastasizing leiomyoma in retroperitoneal lymph nodes with concurrent early stage cervical cancer
by: Danielle Glassman, et al.
Published: (2022) -
Explore the Usefulness of Concurrent Chemotherapy in Stage II Nasopharyngeal Carcinoma: A Retrospective Study
by: Pei-Jing Li, et al.
Published: (2021) -
Conservative management of Oral Submucous Fibrosis in early and intermediate stage
by: Sachin Rai, et al.
Published: (2018) -
Comparison of adjuvant chemoradiotherapy versus radiotherapy in early-stage cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis
by: Qingmin Guo, et al.
Published: (2022) -
Radiotherapy Combined With Concurrent Nedaplatin-Based Chemotherapy for Stage II-III Esophageal Squamous Cell Carcinoma
by: Huiping Zhu MD, et al.
Published: (2022)